Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071838
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2003-10-31
Brief Title:
Zenapax Daclizumab to Treat Relapsing Remitting Multiple Sclerosis
Sponsor:
National Institute of Neurological Disorders and Stroke NINDS
Organization:
National Institutes of Health Clinical Center CC